Leiderman Elisabeth
SEC insider (Form 3/4/5 filer). CIK 0001842133. Director at Autolus Therapeutics plc (AUTL) and 1 other issuer. 5 reported Form 4/5 transactions since Sep 2024; latest on Jun 29, 2026. Located in LONDON.
Companies Leiderman Elisabeth has filed insider reports for
- Autolus Therapeutics plc (AUTL): Director
- bluebird bio, Inc. (BLUE): Director
Leiderman Elisabeth
CIK: 0001842133
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (60.0%)
Compensation grants
Other (G, F, J, C, D, …)2 (40.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Jun 29, 2026AUTL
Autolus Therapeutics plc
AwardDirectRestricted Share Units
31.7K shares- - Jun 29, 2026AUTL
Autolus Therapeutics plc
AwardDirectShare Option (Right to Buy)
47.5K shares- - Jun 2, 2025BLUE
bluebird bio, Inc.
DispositionDirect1.2K shares- - May 30, 2025BLUE
bluebird bio, Inc.
Tender OfferDirect1.1K shares- - Nov 6, 2024BLUE
bluebird bio, Inc.
AwardDirect24.9K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 29, 2026 |  AUTL Autolus Therapeutics plc | Award Restricted Share Units | 31,667 | - | - | Direct |
| Jun 29, 2026 | AUTL Autolus Therapeutics plc | Award Share Option (Right to Buy) | 47,500 | - | - | Direct |
| Jun 2, 2025 |  BLUE bluebird bio, Inc. | Disposition | 1,245 | - | - | Direct |
| May 30, 2025 | BLUE bluebird bio, Inc. | Tender Offer | 1,112 | - | - | Direct |
| Nov 6, 2024 | BLUE bluebird bio, Inc. | Award | 24,900 | - | $0 | Direct |
1-5 of 5 transactions